Physician profile
Mohammad Mojadidi
NPI 1043571029
$194.97
in general payments reported to CMS, 2019-2025
6 companies · $30.93 in 2025
The $30.93 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.11 · 2023: $39.68 · 2024: $111 · 2025: $30.93.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $159 · Entertainment: $23.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $158.74 |
| Entertainment | $23.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $54.05 | 2023-2025 | |
| Abiomed | $42.75 | 2024 | Impella |
| Inspire Medical Systems, INC. | $30.67 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $29.76 | 2023-2024 | Farxiga |
| Becton, Dickinson and Company | $24.63 | 2024 | Rotarexs 6 F X 135 Cm |
| Edwards Lifesciences Corporation | $13.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Mojadidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.